Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan, USA.
Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Am J Ophthalmol. 2020 Aug;216:207-218. doi: 10.1016/j.ajo.2020.02.009. Epub 2020 Feb 19.
To evaluate the association between baseline psychosocial milieu and subsequent glaucoma medication adherence among participants in the Support, Educate, Empower (SEE) personalized glaucoma coaching program pilot study.
Prospective cohort study.
Participants (University of Michigan glaucoma patients aged ≥40 years, taking ≥1 glaucoma medication, who self-reported poor adherence) completed a baseline survey that assessed the following: (1) demographics; (2) social network; (3) perceived stress; (4) consideration of future consequences; (5) glaucoma-related distress; and (6) social support. Medication adherence was then monitored electronically for 3 months and the percentage of prescribed doses taken was calculated. The relationship between baseline factors and medication adherence was assessed using univariate and multivariate analysis. Main outcome measure was median percent adherence over 3 months.
Of the 95 study participants, 63% had graduated from college, 55% were white, 35% were African-American, and 97% had insurance. Median adherence over 3 months was 74% ± 21% (±standard deviation, SD). Higher income and more education were significantly associated with better adherence (P < .0001, P = .03). Glaucoma-related distress (mean score 5.6, SD = 3.0) was inversely associated with medication adherence on univariate (P < .0001) and multivariate analysis (P = .0002). Every 1-point increase in glaucoma-related distress score predicted a 2.4-percentage-point decrease in medication adherence.
Lower income, lower educational attainment, and a higher level of glaucoma-related distress all predicted lower adherence to glaucoma medications. Additional glaucoma self-management support resources should be directed toward patients with such risk factors for poor adherence.
评估支持、教育、赋权(SEE)个性化青光眼辅导计划试点研究中参与者的基线心理社会环境与随后的青光眼药物治疗依从性之间的关系。
前瞻性队列研究。
参与者(密歇根大学年龄≥40 岁的青光眼患者,服用≥1 种青光眼药物,自我报告药物治疗依从性差)完成了一项基线调查,评估了以下内容:(1)人口统计学;(2)社会网络;(3)感知压力;(4)对未来后果的考虑;(5)与青光眼相关的痛苦;和(6)社会支持。然后通过电子方式监测 3 个月的药物治疗依从性,并计算所服用处方剂量的百分比。使用单变量和多变量分析评估基线因素与药物治疗依从性之间的关系。主要观察指标是 3 个月内的中位数百分比依从率。
在 95 名研究参与者中,63%的人大学毕业,55%是白人,35%是非裔美国人,97%有保险。3 个月内的中位数依从率为 74%±21%(±标准差,SD)。较高的收入和更多的教育与更好的依从性显著相关(P<0.0001,P=0.03)。青光眼相关痛苦(平均得分 5.6,SD=3.0)在单变量(P<0.0001)和多变量分析(P=0.0002)中与药物治疗依从性呈负相关。青光眼相关痛苦评分每增加 1 分,药物治疗依从性就会降低 2.4 个百分点。
较低的收入、较低的教育程度和较高的青光眼相关痛苦都预示着对青光眼药物治疗的依从性降低。应针对依从性差的高危患者提供更多的青光眼自我管理支持资源。